Chad V. Pecot
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- RNA Interference and Gene Delivery 5
- Angiogenesis and VEGF in Cancer 5
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 4
-
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 9
- Co-authors
- Anil K. Sood (19 shared papers)Gabriel Lopez‐Berestein (9 shared papers)George A. Calin (1 shared paper)Robert L. Coleman (2 shared papers)Rajesha Rupaimoole (8 shared papers)Jillian L. Perry (4 shared papers)J. Christopher Luft (2 shared papers)Joseph M. DeSimone (2 shared papers)
- Journals
- Nature Communications (4 papers)Oncogene (3 papers)Cancer Research (3 papers)Gynecologic Oncology (3 papers)Journal of Visualized Experiments (2 papers)
- Partner nations
- United StatesGermanyRussia
In The Last Decade
Chad V. Pecot
57 papers receiving 3.1k citations
Chad V. Pecot's Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 1.0k
- Oncology 848
- Molecular Biology 1.7k
- Biomaterials 299
- Immunology 386
Countries citing papers authored by Chad V. Pecot
This map shows the geographic impact of Chad V. Pecot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad V. Pecot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad V. Pecot more than expected).
Fields of papers citing papers by Chad V. Pecot
This network shows the impact of papers produced by Chad V. Pecot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad V. Pecot. The network helps show where Chad V. Pecot may publish in the future.
Co-authors
The 25 scholars most cited alongside Chad V. Pecot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNA interference in the clinic: challenges and future directions Hit paper breakdown → | 2010 | 691 |
| 2 | 2013 | 318 | |
| 3 | 2017 | 225 | |
| 4 | 2014 | 191 | |
| 5 | 2011 | 172 | |
| 6 | 2013 | 159 | |
| 7 | 2019 | 112 | |
| 8 | 2015 | 104 | |
| 9 | 2022 | 81 | |
| 10 | 2016 | 81 | |
| 11 | 2014 | 75 | |
| 12 | 2019 | 70 | |
| 13 | 2019 | 68 | |
| 14 | 2019 | 61 | |
| 15 | Rapid idiosyncratic mechanisms of clinical resistance to KRAS G12C inhibition | 2022 | 59 |
| 16 | 2021 | 57 | |
| 17 | 2022 | 55 | |
| 18 | 2015 | 51 | |
| 19 | 2020 | 51 | |
| 20 | 2020 | 50 |
About Chad V. Pecot
Chad V. Pecot is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 61 papers that have together received 3.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (9 papers), Cell Adhesion Molecules Research (7 papers), RNA Interference and Gene Delivery (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Epigenetics and DNA Methylation (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (848 citations), Molecular Biology (1.7k citations), Biomaterials (299 citations) and Immunology (386 citations). Chad V. Pecot has collaborated with scholars based in United States, Germany and Russia. Frequent co-authors include Anil K. Sood, Gabriel Lopez‐Berestein, George A. Calin, Robert L. Coleman, Rajesha Rupaimoole, Jillian L. Perry, J. Christopher Luft, Joseph M. DeSimone, Kevin Reuter and Salma H. Azam. Their work appears in journals such as Nature Communications, Oncogene, Cancer Research, Gynecologic Oncology and Journal of Visualized Experiments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.